Rivastigmine in subcortical vascular dementia: An open 22 month study

被引:69
作者
Moretti, R
Torre, P
Antonello, RM
Cazzato, G
Bava, A
机构
[1] Univ Studi Trieste, Dipartimento Fisiol & Patol, I-34149 Trieste, Italy
[2] Univ Trieste, Dipartimento Med Clin & Neurol, Trieste, Italy
关键词
behaviour; cholinesterase inhibition; executive function; rivastigmine; vascular dementia;
D O I
10.1016/S0022-510X(02)00280-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Further to recent data indicating that patients with vascular dementia (VaD) show a cholinergic deficit, we aimed to determine whether rivastigmine, a dual inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), has any effects on the symptoms of VaD. Patients aged 65-80, with a diagnosis of dementia and probable VaD, received rivastigmine 3-6 mg/day (n = 8) or cardioaspirin (n = 8) in an open study for 22 months. At 22 months, patients treated with rivastigmine showed significant improvements in executive function and behavioural symptoms (both p < 0.05 vs. both baseline and control group), which were reflected in reduced caregiver stress (p < 0.05 vs. baseline and controls). Baseline scores of global response, cognition, word fluency and activities of daily living were maintained in patients receiving rivastigmine, and there was no increase in benzodiazepine or neuroleptic intake. In contrast, the control group showed no improvements in any domain, and significant deterioration in global response and executive function (both p < 0.05 vs. baseline and rivastigmine group). Side effects in both groups were tolerable and there were no study withdrawals. Long-term rivastigmine treatment appeared to be safe and effective in this patient population. In particular, improvements in domains particularly relevant to this condition were observed. These benefits may reflect the drug's dual inhibitory effects on the cholinergic system, and its particular activity in frontal areas of the brain. A large, double-blind study of rivastigmine in patients with VaD would be worthwhile. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 41 条
[1]  
[Anonymous], 1998, Int J Geriatr Psychopharmacol
[2]  
CHUI H, 2001, DEMENTIA ASS SUBCORT
[3]   DEMENTIA - A REVIEW EMPHASIZING CLINICOPATHOLOGIC CORRELATION AND BRAIN-BEHAVIOR RELATIONSHIPS [J].
CHUI, HC .
ARCHIVES OF NEUROLOGY, 1989, 46 (07) :806-814
[4]   THE NEUROPSYCHIATRIC INVENTORY - COMPREHENSIVE ASSESSMENT OF PSYCHOPATHOLOGY IN DEMENTIA [J].
CUMMINGS, JL ;
MEGA, M ;
GRAY, K ;
ROSENBERGTHOMPSON, S ;
CARUSI, DA ;
GORNBEIN, J .
NEUROLOGY, 1994, 44 (12) :2308-2314
[5]   FRONTAL-SUBCORTICAL CIRCUITS AND HUMAN-BEHAVIOR [J].
CUMMINGS, JL .
ARCHIVES OF NEUROLOGY, 1993, 50 (08) :873-880
[6]   CT IN THE DIFFERENTIAL-DIAGNOSIS BETWEEN ALZHEIMERS-DISEASE AND VASCULAR DEMENTIA [J].
ERKINJUNTTI, T ;
KETONEN, L ;
SULKAVA, R ;
VUORIALHO, M ;
PALO, J .
ACTA NEUROLOGICA SCANDINAVICA, 1987, 75 (04) :262-270
[7]   Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial [J].
Erkinjuntti, T ;
Kurz, A ;
Gauthier, S ;
Bullock, R ;
Lilienfeld, S ;
Damaraju, CV .
LANCET, 2002, 359 (9314) :1283-1290
[8]  
ERKINJUTTI T, 1997, INT PSYCHOGERIATR, V9, P77
[9]   A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease [J].
Farlow, M ;
Anand, R ;
Messina, J ;
Hartman, R ;
Veach, J .
EUROPEAN NEUROLOGY, 2000, 44 (04) :236-241
[10]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198